Eleftherios P Diamandis Selected Research

Ligands

5/2022	Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line.
11/2018	Optimizing cancer immunotherapy: Is it time for personalized predictive biomarkers?
2/2014	Proteomic signatures of angiogenesis in androgen-independent prostate cancer.
8/2008	Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
6/2008	An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleftherios P Diamandis Research Topics

Disease

218	Neoplasms (Cancer) 01/2024 - 03/2002
78	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 04/2002
74	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2002
57	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2002
25	Carcinoma (Carcinomatosis) 01/2023 - 01/2002
23	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 05/2002
19	Ascites 07/2019 - 05/2003
17	Inflammation (Inflammations) 01/2023 - 06/2006
14	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2002
11	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2004
10	Adenocarcinoma 03/2014 - 08/2002
9	Disease Progression 08/2023 - 01/2008
9	Carcinogenesis 08/2018 - 09/2002
9	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 12/2008
8	Male Infertility (Male Sterility) 01/2019 - 12/2011
6	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2008
6	Colonic Neoplasms (Colon Cancer) 02/2015 - 01/2004
5	Cognitive Dysfunction 01/2023 - 02/2016
5	Dementia (Dementias) 01/2020 - 02/2016
5	Arthritis (Polyarthritis) 01/2019 - 02/2013
5	Azoospermia 01/2017 - 03/2008
5	Testicular Neoplasms (Testicular Cancer) 12/2008 - 05/2002
4	COVID-19 01/2023 - 01/2021
4	Infections 01/2022 - 07/2007
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 09/2013
4	Residual Neoplasm 07/2019 - 02/2003
4	Osteoarthritis 01/2018 - 02/2013
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2006
4	Psoriatic Arthritis 01/2018 - 01/2014
4	Pathologic Processes 01/2018 - 07/2011
4	Down Syndrome (Down's Syndrome) 02/2013 - 07/2010
4	Ovarian Epithelial Carcinoma 10/2009 - 08/2003
4	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2005 - 02/2003
3	Glioma (Gliomas) 03/2023 - 08/2009
3	Multiple Sclerosis 01/2023 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 06/2014
3	Melanoma (Melanoma, Malignant) 01/2023 - 07/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 03/2012
3	renal Oncocytoma 01/2020 - 12/2019
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2009
3	Kidney Diseases (Kidney Disease) 01/2020 - 08/2013
3	Skin Diseases (Skin Disease) 10/2019 - 05/2008
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 08/2017

Drug/Important Bio-Agent (IBA)

179	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2002
142	Kallikreins (Kallikrein)IBA 01/2023 - 01/2002
124	Proteins (Proteins, Gene)FDA Link 03/2023 - 05/2002
49	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 03/2003
39	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 05/2002
38	Tissue Kallikreins (Tissue Kallikrein)IBA 08/2018 - 05/2002
37	Prostate-Specific Antigen (Semenogelase)IBA 01/2023 - 01/2002
32	Messenger RNA (mRNA)IBA 01/2023 - 05/2002
29	Serine Proteases (Serine Protease)IBA 11/2022 - 01/2004
27	Hormones (Hormone)IBA 01/2019 - 05/2002
25	ProteomeIBA 01/2021 - 01/2007
23	SteroidsIBA 11/2008 - 05/2002
21	EnzymesIBA 01/2020 - 05/2003
18	AntigensIBA 01/2024 - 11/2005
16	Peptides (Polypeptides)IBA 01/2020 - 06/2006
13	AndrogensIBA 01/2019 - 03/2002
12	Circulating Tumor DNAIBA 05/2022 - 01/2016
10	AutoantibodiesIBA 04/2024 - 03/2009
10	Androgen Receptors (Androgen Receptor)IBA 05/2022 - 03/2002
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2002
9	MicroRNAs (MicroRNA)IBA 01/2020 - 06/2008
9	Indicators and Reagents (Reagents)IBA 07/2019 - 08/2002
9	Estrogens (Estrogen)FDA Link 01/2019 - 03/2002
8	Complement System Proteins (Complement)IBA 01/2024 - 11/2005
8	Blood Proteins (Serum Proteins)IBA 03/2023 - 02/2005
8	Conditioned Culture MediaIBA 02/2014 - 03/2007
7	Proteinase-Activated ReceptorsIBA 01/2023 - 06/2008
7	Tissue ExtractsIBA 01/2016 - 05/2002
6	Monoclonal AntibodiesIBA 01/2021 - 02/2006
6	TrypsinIBA 03/2020 - 10/2004
6	ImmunosorbentsIBA 11/2019 - 02/2004
6	Amino Acids FDA Link 08/2017 - 05/2002
5	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2016
5	Amyloid (Amyloid Fibrils)IBA 01/2023 - 03/2003
5	LigandsIBA 05/2022 - 06/2008
5	rat KLK7 proteinIBA 10/2020 - 04/2009
5	FollistatinIBA 01/2016 - 08/2008
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2014 - 01/2002
5	RNA (Ribonucleic Acid)IBA 11/2013 - 08/2002
5	Carcinoembryonic AntigenIBA 01/2013 - 12/2008
4	AutoantigensIBA 01/2023 - 01/2019
4	Apolipoproteins E (ApoE)IBA 11/2022 - 02/2014
4	Protein Isoforms (Isoforms)IBA 08/2017 - 05/2003
4	IsotopesIBA 01/2017 - 11/2011
4	Plasminogen Activator Inhibitor 1IBA 04/2014 - 08/2006
4	CollagenIBA 03/2012 - 08/2003
4	PlatinumIBA 03/2009 - 03/2007
4	Progestins (Progestagens)IBA 11/2003 - 10/2002
3	Glycoproteins (Glycoprotein)IBA 01/2023 - 07/2013
3	VaccinesIBA 01/2022 - 06/2013
3	neuronal pentraxin receptorIBA 01/2020 - 11/2019
3	Cell-Free Nucleic AcidsIBA 01/2019 - 01/2018
3	Progesterone FDA LinkGeneric 01/2019 - 08/2002

Therapy/Procedure

34	Therapeutics 01/2023 - 05/2003
9	Drug Therapy (Chemotherapy) 01/2019 - 02/2003
8	Prostatectomy (Retropubic Prostatectomy) 10/2020 - 01/2004
4	Immunotherapy 01/2023 - 05/2016